Assembly Biosciences, Inc. (ASMB) vs YD Bio Limited Ordinary Shares (YDES)
A side-by-side comparison of Assembly Biosciences, Inc. and YD Bio Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASMB
Assembly Biosciences, Inc.
$22.18HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
YDES
YD Bio Limited Ordinary Shares
$6.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ASMB vs YDES
growth of $100 · dividends reinvested · last 1yASMB +23.6% (+23.6%/yr)YDES -40.9% (-40.9%/yr)ASMB compounded faster over this window
ASMB YDES
ASMB vs YDES: by the numbers
- •ASMB is the larger company ($440M vs $436M market cap).
- •Both run net losses; ASMB's is the smaller (-0.06% vs -1392.61% net margin).
Metrics side by side
Valuation
| Metric | ASMB | YDES |
|---|---|---|
| P/E ratio | 40.33 | N/A |
| P/S ratio | 5.87 | N/A |
| P/B ratio | 1.44 | N/A |
Profitability
| Metric | ASMB | YDES |
|---|---|---|
| Gross margin | 99.82% | -7.06% |
| Operating margin | -11.75% | -883.31% |
| Net margin | -0.06% | -1392.61% |
| ROE | -0.01% | -66.49% |
| ROIC | -2.86% | N/A |
Growth (annualized)
| Metric | ASMB | YDES |
|---|---|---|
| Revenue CAGR (5Y) | -1.78% | N/A |
| Total return CAGR (5Y) | -10.66% | N/A |
Go deeper
Dig into the metrics
Assembly Biosciences P/E ratioAssembly Biosciences ROEYD Bio Limited Ordinary Shares ROEAssembly Biosciences operating marginYD Bio Limited Ordinary Shares operating marginAssembly Biosciences revenue growthYD Bio Limited Ordinary Shares revenue growthAssembly Biosciences free cash flowYD Bio Limited Ordinary Shares free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.